Pharma Regulatory Asia Summit 2013

Pharma Regulatory Asia Summit 2013

1^st time in China!

Subject: New Pharma Regulatory Summit in China – Exclusive Discount for Past Attendees

Pharma Regulatory Asia Summit forms part of IBC’s Regulatory Series, and is the longest standing event of its kind in the region. For the first time in 2013, Pharma Regulatory Asia Summit will be launched in China, with a focus on North Asia, particularly China, Korea, Japan and Taiwan.

Pharma Regulatory Asia Summit 2013 is scheduled at the Westin Beijing Chaoyang during Mar. 6-8, 2013. Pharma Regulatory Asia Summit 2013 will be an opportunity for industry and authorities to discuss and collaborate with a view to deliver safe and effective medicines to the Asian population in a timely manner.

China is expected to be the second largest pharmaceutical market by 2015 – make sure you can capitalize on your market share by having a thorough understanding of the processes and the right contacts in the industry

Featuring presentations from 20+ regulatory experts and interactive formats, Pharma Regulatory Asia Summit 2013 will provide you with the unique opportunity to network and share experiences with a targeted group of peers from across China, Rest of North Asia, South East Asia, Europe, US and Australia.

Hear from leading China industry and authority experts at IBC’s Pharma Regulatory Summit Asia
* Understand the drug registration process in China, including overcoming challenges and optimizing opportunities
* Gain updates on how the USP-China are working with the SFDA to harmonise quality standards
* Don’t miss key insights on challenges, approaches and progress on the implementation of current GMP in China
* Take-away key lessons on the regulatory requirements for designing clinical trials for registration in China

PLUS! Regional perspectives and practical advice on the regulatory approval process in:
•  Korea
•  Taiwan
•  Japan
•  Hong Kong